A Targeted, Minimally Invasive Treatment to Control Liver Tumors
When cancer affects the liver—especially primary liver cancer (Hepatocellular Carcinoma) or tumors that have spread to the liver—not everyone can have surgery.
Transarterial Chemoembolization (TACE) is a minimally invasive, image-guided treatment that delivers chemotherapy directly to the tumor and blocks its blood supply, helping to shrink or control the tumor while protecting the rest of the body from high doses of chemotherapy.
Transarterial Chemoembolization (TACE) is a procedure where:
This double action:
TACE is most commonly used for:
Targeted treatment
Minimally invasive
No big surgery
Faster recovery
Can be repeated if needed
TACE is done when:
Main goals:
TACE is performed by an interventional radiologist in a cath lab using X-ray guidance.
Step-by-step:
TACE is widely used and generally safe in experienced centers. Possible risks with approximate incidence include:
Your treatment options depend on:
In many cases, a combination of treatments may offer the best results.
Alternative 1: No Active Treatment (Supportive Care)
Alternative 2: TARE (Transarterial Radioembolization)
Alternative 3: Tumor Ablation
Alternative 4: Surgery or Liver Transplant
Alternative 5: External Beam Radiation Therapy
Alternative 6: Cancer Medicines and Immunotherapy
Choosing the Right Liver Cancer Treatment
Modern liver cancer care often uses a multidisciplinary approach, combining minimally invasive procedures, surgery, radiation, and medicines to achieve the best possible outcome. A personalized evaluation helps choose the most effective and safest treatment plan.
📌 TACE is often chosen when surgery is not possible and a strong local treatment is needed.
After TACE:
TACE is a minimally invasive cancer treatment that delivers chemotherapy directly into the blood vessels feeding a liver tumor and then blocks those vessels to cut off the tumor’s blood supply.
TACE is most commonly used for:
No. TACE is a catheter-based, minimally invasive procedure, not open surgery.
You won’t feel pain during the procedure. Pain, fever, or tiredness for a few days afterward is common and treated with medicines.
The procedure usually takes 1 to 2 hours, depending on the number and size of tumors.
Most patients stay in the hospital for 1 to 2 days for observation and symptom control.
TACE often shrinks or controls the tumor and slows disease progression. In some cases, it helps make surgery or liver transplant possible.
TACE is very effective in controlling liver tumors in many patients and is a standard treatment worldwide for inoperable liver cancer.
Some patients need one session, while others may need repeat treatments, depending on how the tumor responds.
Common side effects include fever, pain, nausea, and tiredness for a few days. Less common risks include infection, bleeding, liver function worsening, or non-target embolization. Serious complications are uncommon.
Post-embolization syndrome is a temporary reaction after TACE that includes fever, abdominal pain, nausea, and fatigue. It usually settles in a few days with medicines.
Yes. TACE is often combined with ablation, surgery, targeted therapy, or immunotherapy, depending on the cancer stage and treatment plan.
TACE is commonly used in patients with liver disease, but careful testing of liver function is done first to make sure it is safe.
Most patients return to normal daily activities within 5 to 7 days, depending on recovery and symptoms.
Yes. TACE is available in advanced cancer and interventional radiology centers across India.
If you or your loved one has liver cancer or liver tumors not suitable for surgery, Transarterial Chemoembolization (TACE) can be a powerful treatment option.
